CRISPR-Cas9-mediated loss-of-function screens

References

• Adamson B, Norman TM, Jost M, Parnas O, Regev A, Weissman JS. 2016. A multiplexed single-cell CRISPR screening platform enables systematic dissection of the unfolded protein response. Cell. 67(7):1867–1882.e21. doi: 10.1016/j.cell.2016.11.048
   Google Scholar
• Adhemar D. 2014. Massively parallel single-cell RNA-seq for marker-free decomposition of tissues into cell types. Science. 343(6172):776–779. doi: 10.1126/science.1247651
   PubMed Web of Science ®Google Scholar
• Aguirre AJ, Meyers RM, Weir BA. 2017. Genomic copy number dictates a gene-independent cell response to CRISPR-Cas9 targeting. Cancer Discov. 6(8):914–929. doi: 10.1158/2159-8290.CD-16-0154
   Web of Science ®Google Scholar
• Ali N, Karlsson C, Aspling M, Larsson J. 2009. Forward RNAi screens in primary human hematopoietic stem/progenitor cells. Blood. 113(16):3690–3695. doi: 10.1182/blood-2008-10-176396
   PubMed Web of Science ®Google Scholar
• Bae S, Park J, Kim JS. 2014. Cas-OFFinder: a fast and versatile algorithm that searches for potential off-target sites of Cas9 RNA-guided endonucleases. Bioinformatics. 30(10):1473–1475. doi: 10.1093/bioinformatics/btu048
   PubMed Web of Science ®Google Scholar
• Baggen J, Jan H, Staring J. 2016. Enterovirus D68 receptor requirements unveiled by haploid genetics. Proc Natl Acad Sci USA. 113(5):1399–1404. doi: 10.1073/pnas.1524498113
   PubMed Web of Science ®Google Scholar
• Bikard D, Jiang W, Samai P, Hochschild A, Zhang F, Marraffini LA. 2013. Programmable repression and activation of bacterial gene expression using an engineered CRISPR-Cas system. Nucleic Acids Res. 41(15):7429–7437. doi: 10.1093/nar/gkt520
   PubMed Web of Science ®Google Scholar
• Bitinaite J, Wah DA, Aggarwal AK, Schildkraut I. 1998. FokI dimerization is required for DNA cleavage. Proc Natl Acad Sci USA. 95(18):10570–10575. doi: 10.1073/pnas.95.18.10570
   PubMed Web of Science ®Google Scholar
• Brenner S. 1974. The genetics of Caenorhabdztzs elegans. Genetics. 77:71–94.
   PubMed Web of Science ®Google Scholar
• Broome JD. 1963. Evidence that the L-asparaginase activity of Guinea pig serum is responsible for its antilymphoma effects. J Exp Med. 118:99–120. doi: 10.1084/jem.118.1.99
   PubMed Web of Science ®Google Scholar
• Chavez A, Scheiman J, Vora S. 2015. Highly efficient Cas9-mediated transcriptional programming. Nat Methods. 12(4):326–328. doi: 10.1038/nmeth.3312
   PubMed Web of Science ®Google Scholar
• Cho SW, Kim S, Kim JM, Kim J. 2013. Targeted genome engineering in human cells with the Cas9 RNA-guided endonuclease. Nat Biotechnol. 31(3):230–232. doi: 10.1038/nbt.2507
   PubMed Web of Science ®Google Scholar
• Concordet JP, Haeussler M. 2018. CRISPOR: intuitive guide selection for CRISPR/Cas9 genome editing experiments and screens. Nucleic Acids Res. 46(W1):W242–W245. doi: 10.1093/nar/gky354
   PubMed Web of Science ®Google Scholar
• Cong L, Zhang F. 2015. Genome engineering using the CRISPR-Cas9 system. Methods Mol Biol. 1239:197–217. doi: 10.1007/978-1-4939-1862-1_10
   PubMedGoogle Scholar
• Conte D, Mello CC. 2003. RNA interference in Caenorhabditis elegans. Curr Protoc Mol Biol. 109:26.3.1–30.
   Google Scholar
• Datlinger P, Rendeiro AF, Schmidl C. 2017. Pooled CRISPR screening with single-cell transcriptome read- out. Nat Methods. 14(3):297–301. doi: 10.1038/nmeth.4177
   PubMed Web of Science ®Google Scholar
• Deltcheva E, Chylinski K, Sharma CM. 2011. CRISPR RNA maturation by trans-encoded small RNA and host factor RNase III. Nature. 471(7340):602–607. doi: 10.1038/nature09886
   PubMed Web of Science ®Google Scholar
• Dixit A, Parnas O, Li B. 2016. Perturb-seq: dissecting molecular circuits with scalable single cell RNA profiling of pooled genetic screens. Cell. 167(7):1853–1866.e17. doi: 10.1016/j.cell.2016.11.038
   PubMed Web of Science ®Google Scholar
• Dominguez AA, Lim WA, Qi LS. 2016. Beyond editing: repurposing CRISPR–Cas9 for precision genome regulation and interrogation. Nat Rev Mol Cell Biol. 17(1):5–15. doi: 10.1038/nrm.2015.2
   PubMed Web of Science ®Google Scholar
• Dunham I, Kundaje A, Aldred SF. 2012. An integrated encyclopedia of DNA elements in the human genome. Nature. 489(7414):57–74. doi: 10.1038/nature11247
   PubMed Web of Science ®Google Scholar
• Fong PC, Boss DS, Yap TA. 2009. Inhibition of poly(ADP-ribose) polymerase in tumors from BRCA mutation carriers. N Engl J Med. 361(2):123–134. doi: 10.1056/NEJMoa0900212
   PubMed Web of Science ®Google Scholar
• Fortin JP, Tan J, Gascoigne KE. 2019. Multiple-gene targeting and mismatch tolerance can confound analysis of genome-wide pooled CRISPR screens. Genome Biol. 20(1):21. doi: 10.1186/s13059-019-1621-7
   PubMedGoogle Scholar
• Fu Y, Sander JD, Reyon D, Cascio VM, Joung JK. 2014. Improving CRISPR-Cas nuclease specificity using truncated guide RNAs. Nat Biotechnol. 32(3):279–284. doi: 10.1038/nbt.2808
   PubMed Web of Science ®Google Scholar
• Gans M, Audit C, Masson M. 1975. Isolation and characterization of sex-linked female- sterile mutants in Drosophila melanogaster. Genetics. 81(4):683–704.
   PubMed Web of Science ®Google Scholar
• Gilbert LA, Horlbeck MA, Adamson B. 2014. Genome-scale CRISPR-mediated control of gene repression and activation. Cell. 159(3):647–661. doi: 10.1016/j.cell.2014.09.029
   PubMed Web of Science ®Google Scholar
• Gilbert LA, Larson MH, Morsut L. 2013. CRISPR-mediated modular RNA-guided regulation of transcription in eukaryotes. Cell. 154(2):442–451. doi: 10.1016/j.cell.2013.06.044
   PubMed Web of Science ®Google Scholar
• Groff AF, Sanchez-Gomez DB, Soruco MML. 2016. In vivo characterization of Linc-p21 reveals functional cis-regulatory DNA elements. Cell Rep. 16(8):2178–2186. doi: 10.1016/j.celrep.2016.07.050
   PubMed Web of Science ®Google Scholar
• Guilinger JP, Thompson DB, Liu DR. 2014. Fusion of catalytically inactive Cas9 to FokI nuclease improves the specificity of genome modification. Nat Biotechnol. 32(6):577–582. doi: 10.1038/nbt.2909
   PubMed Web of Science ®Google Scholar
• Habib N, Hsu PD, Wu X, Jiang W, Luciano A. 2013. Multiplex genome engineering using CRISPR / Cas systems. Science. 339(6121):819–823. doi: 10.1126/science.1231143
   PubMed Web of Science ®Google Scholar
• Han K, Jeng EE, Hess GT, Bassik MC. 2017. Synergistic drug combinations for cancer identified in a CRISPR screen for pairwise genetic interactions. Nat Biotechnol. 35(5):463–474. doi: 10.1038/nbt.3834
   PubMed Web of Science ®Google Scholar
• Hart T, Brown KR, Sircoulomb F, Moffat J. 2018. Measuring error rates in genomic perturbation screens: gold standards for human functional genomics. Mol Syst Bio. 10:733. doi: 10.15252/msb.20145216
   Google Scholar
• Hart T, Chandrashekhar M, Aregger M. 2015. High-resolution CRISPR screens reveal fitness genes and genotype-specific cancer liabilities. Cell. 163(6):1515–1526. doi: 10.1016/j.cell.2015.11.015
   PubMed Web of Science ®Google Scholar
• Hinze L, Pfirrmann M, Karim S. 2019. Synthetic lethality of wnt pathway activation and asparaginase in drug-resistant acute leukemias. Cancer Cell. 35(4):664–676.e7. doi: 10.1016/j.ccell.2019.03.004
   PubMed Web of Science ®Google Scholar
• Horvath P, Barrangou R. 2010. CRISPR/cas, the immune system of bacteria and archaea. Science. 327(5962):167–170. doi: 10.1126/science.1179555
   PubMed Web of Science ®Google Scholar
• Hutchinson L. 2010. Targeted therapies: PARP inhibitor olaparib is safe and effective in patients with BRCA1 and BRCA2 mutations. Nat Rev Clin Oncol. 7(10):549. doi: 10.1038/nrclinonc.2010.143
   PubMedGoogle Scholar
• Jaitin DA, Weiner A, Yofe I. 2016. Dissecting immune circuits by linking crispr- pooled screens with single-cell RNA-Seq. Cell. 167(7):1883–1888.e15. doi: 10.1016/j.cell.2016.11.039
   PubMed Web of Science ®Google Scholar
• Ji W, Lee D, Wong E. 2014. Specific gene repression by CRISPRi system transferred through bacterial conjugation. ACS Synth Biol. 3(12):929–931. doi: 10.1021/sb500036q
   PubMed Web of Science ®Google Scholar
• Jiang W, Bikard D, Cox D, Zhang F, Marraffini LA. 2013. RNA-guided editing of bacterial genomes using CRISPR-Cas systems. Nat Biotechnol. 31(3):233–239. doi: 10.1038/nbt.2508
   PubMed Web of Science ®Google Scholar
• Jinek M, Chylinski K, Fonfara I, Hauer M, Doudna JA, Charpentier E. 2012. Cas9-crRNA ribonucleoprotein complex mediates specific DNA cleavage for adaptive immunity in bacteria. Proc Natl Acad Sci USA. 109(39):E2579–E2586. doi: 10.1073/pnas.1208507109
   PubMed Web of Science ®Google Scholar
• Khorashad JS, Eiring AM, Mason CC. 2015. shRNA library screening identifies nucleocytoplasmic transport as a mediator of BCR-ABL1 kinase-independent resistance. Blood. 125(11):1772–1781. doi: 10.1182/blood-2014-08-588855
   PubMed Web of Science ®Google Scholar
• Kim D, Bae S, Park J. 2015. Digenome-seq: genome-wide profiling of CRISPR-Cas9 off-target effects in human cells. Nat Methods. 12(3):237–243. 1 p following 243. doi: 10.1038/nmeth.3284
   PubMed Web of Science ®Google Scholar
• Kim HS, Lee K, Bae S. 2017. CRISPR / Cas9-mediated gene knockout screens and target identification via whole-genome sequencing uncover host genes required for picornavirus infection. J Biol Chem. 292(25):10664–10671. doi: 10.1074/jbc.M117.782425
   PubMed Web of Science ®Google Scholar
• Konermann S, Brigham MD, Trevino AE. 2015. Genome-scale transcriptional activation by an engineered CRISPR-Cas9 complex. Nature. 517(7536):583–588. doi: 10.1038/nature14136
   PubMed Web of Science ®Google Scholar
• Labun K, Montague TG, Gagnon JA, Thyme SB, Valen E. 2016. CHOPCHOP v2: a web tool for the next generation of CRISPR genome engineering. Nucleic Acids Res. 44(W1):W272–W276. doi: 10.1093/nar/gkw398
   PubMed Web of Science ®Google Scholar
• Li W, Xu H, Xiao T. 2014. MAGeCK enables robust identification of essential genes from genome-scale CRISPR/Cas9 knockout screens. Genome Biol. 15(12):554. doi: 10.1186/s13059-014-0554-4
   PubMed Web of Science ®Google Scholar
• Lin Y, Cradick TJ, Brown MT. 2014. CRISPR/cas9 systems have off-target activity with insertions or deletions between target DNA and guide RNA sequences. Nucleic Acids Res. 42(11):7473–7485. doi: 10.1093/nar/gku402
   PubMed Web of Science ®Google Scholar
• Liu SJ, Horlbeck MA, Cho SW. 2017. CRISPRi-based genome-scale identification of functional long non-coding RNA loci in human cells. Science. 355:6320. doi: 10.1126/science.aah4712
   Web of Science ®Google Scholar
• Liu R, Paxton WA, Choe S. 1996. Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection. Cell. 86(3):367–377. doi: 10.1016/S0092-8674(00)80110-5
   PubMed Web of Science ®Google Scholar
• Marceau CD, Puschnik AS, Majzoub K. 2017. Genetic dissection of Flaviviridae host factors through genome- scale CRISPR screens. Nature. 535(7610):159–163. doi: 10.1038/nature18631
   Web of Science ®Google Scholar
• Nüsslein-volhard C, Wieschaus E. 1980. Mutations affecting segment number and polarity in Drosophila. Nature. 287(5785):795–801. doi: 10.1038/287795a0
   PubMed Web of Science ®Google Scholar
• Pagliarini R, Shao W, Sellers WR. 2015. Oncogene addiction: pathways of therapeutic response, resistance, and road maps toward a cure. EMBO Rep. 16(3):280–296. doi: 10.15252/embr.201439949
   PubMed Web of Science ®Google Scholar
• Paralkar VR, Taborda CC, Huang P. 2016. Unlinking an lncRNA from its associated cis element. Mol Cell. 62(1):104–110. doi: 10.1016/j.molcel.2016.02.029
   PubMed Web of Science ®Google Scholar
• Pattanayak V, Lin S, Guilinger JP, Ma E, Doudna JA, Liu DR. 2013. High-throughput profiling of off-target DNA cleavage reveals RNA-programmed Cas9 nuclease specificity. Nat Biotechnol. 31(9):839–843. doi: 10.1038/nbt.2673
   PubMed Web of Science ®Google Scholar
• Ran FA, Hsu PD, Lin CY. 2013. Double nicking by RNA-guided CRISPR Cas9 for enhanced genome editing specificity. Cell. 154(6):1380–1389. doi: 10.1016/j.cell.2013.08.021
   PubMed Web of Science ®Google Scholar
• Rédei GP. 2007. The connectivity map: a new tool for biomedical research. Nat Rev Cancer. 7(1):54–60. doi: 10.1038/nrc2044
   PubMed Web of Science ®Google Scholar
• Ren X, Yang Z, Xu J. 2014. Manuscript A. Enhanced specificity and efficiency of the CRISPR/Cas9 system with optimized sgRNA parameters in Drosophila. Cell Rep. 9(3):1151–1162. doi: 10.1016/j.celrep.2014.09.044
   PubMed Web of Science ®Google Scholar
• Rosenbluh J, Xu H, Harrington W. 2017. Complementary information derived from CRISPR Cas9 mediated gene deletion and suppression. Nat Commun. 8:15403. doi: 10.1038/ncomms15403
   PubMed Web of Science ®Google Scholar
• Sanson KR, Hanna RE, Hegde M, Donovan KF, Strand C, Sullender ME, Doench JG. 2018. Optimized libraries for CRISPR-Cas9 genetic screens with multiple modalities. Nat Commun. 9(1):5416. doi: 10.1038/s41467-018-07901-8
   PubMedGoogle Scholar
• Shalem O, Sanjana NE, Hartenian E, Zhang F. 2014. Genome-scale CRISPR-Cas9 knockout screening in human cells science. Science. 343(6166):84–87. doi: 10.1126/science.1247005
   PubMed Web of Science ®Google Scholar
• Shen JP, Zhao D, Sasik R. 2017. Combinatorial CRISPR-Cas9 screens for de novo mapping of genetic interactions. Nat Methods. 14(6):573–576. doi: 10.1038/nmeth.4225
   PubMed Web of Science ®Google Scholar
• Shi J, Wang E, Milazzo JP, Wang Z, Kinney JB, Vakoc CR. 2015. Discovery of cancer drug targets by CRISPR-Cas9 screening of protein domains. Nat Biotechnol. 33(6):661–667. doi: 10.1038/nbt.3235
   PubMed Web of Science ®Google Scholar
• Sigoillot FD, Lyman S, Huckins JF. 2012. A bioinformatics method identifies prominent off-targeted transcripts in RNAi screens. Nat Methods. 9(4):363–366. doi: 10.1038/nmeth.1898
   PubMed Web of Science ®Google Scholar
• Simeonov DR, Gowen BG, Boontanrart M. 2017. Discovery of stimulation-responsive immune enhancers with CRISPR activation. Nature. 549(7670):111–115. doi: 10.1038/nature23875
   PubMed Web of Science ®Google Scholar
• Smith I, Greenside PG, Natoli T. 2017a. Evaluation of RNAi and CRISPR technologies by large-scale gene expression profiling in the connectivity map. PLoS Biol. 15(11):e2003213. doi: 10.1371/journal.pbio.2003213
   PubMed Web of Science ®Google Scholar
• Smith TS, Heger A, Sudbery I. 2017b. UMI-tools: modeling sequencing errors in Unique Molecular Identifiers to improve quantification accuracy. Genome Res. 27(3):491–499. doi: 10.1101/gr.209601.116
   PubMed Web of Science ®Google Scholar
• Tebas P, Stein D, Tang WW. 2014. Gene editing of CCR5 in autologous CD4 T cells of persons infected with HIV. N Engl J Med. 370(10):901–910. doi: 10.1056/NEJMoa1300662
   PubMed Web of Science ®Google Scholar
• Tsai SQ, Zheng Z, Nguyen NT. 2015. GUIDE-seq enables genome-wide profiling of off-target cleavage by CRISPR-Cas nucleases. Nat Biotechnol. 33(2):187–197. doi: 10.1038/nbt.3117
   PubMed Web of Science ®Google Scholar
• Tzelepis K, Koike-Yusa H, De Braekeleer E. 2016. A CRISPR dropout screen identifies genetic vulnerabilities and therapeutic targets in acute myeloid leukemia. Cell Rep. 17(4):1193–1205. doi: 10.1016/j.celrep.2016.09.079
   PubMed Web of Science ®Google Scholar
• Wang B, Wang M, Zhang W. 2019. Integrative analysis of pooled CRISPR genetic screens using MAGeCKFlute. Nat Protoc. 14(3):756–780. doi: 10.1038/s41596-018-0113-7
   PubMed Web of Science ®Google Scholar
• Wang T, Wei JJ, Sabatini DM, Lander ES. 2014. Genetic screens in human cells using the CRISPR/Cas9 system. Science. 343(6166):80–84. doi: 10.1126/science.1246981
   PubMed Web of Science ®Google Scholar
• Wang H, Yang H, Shivalila CS. 2013. One-step generation of mice carrying mutations in multiple genes by CRISPR/Cas-mediated genome engineering. Cell. 153(4):910–918. doi: 10.1016/j.cell.2013.04.025
   PubMed Web of Science ®Google Scholar
• Wang T, Yu H, Hughes NW. 2017. Gene essentiality profiling reveals gene networks and synthetic lethal interactions with oncogenic ras. Cell. 168(5):890–903.e15. doi: 10.1016/j.cell.2017.01.013
   PubMed Web of Science ®Google Scholar
• Wiedenheft B, Sternberg SH, Doudna JA. 2012. RNA-guided genetic silencing systems in bacteria and archaea. Nature. 482(7385):331–338. doi: 10.1038/nature10886
   PubMed Web of Science ®Google Scholar
• Wong AS, Choi GC, Cui CH. 2016. Multiplexed barcoded CRISPR-Cas9 screening enabled by CombiGEM. Proc Natl Acad Sci USA. 113(9):2544–2549. doi: 10.1073/pnas.1517883113
   PubMed Web of Science ®Google Scholar
• Xie S, Duan J, Li B, Zhou P, Hon GC. 2017. Multiplexed engineering and analysis of combinatorial enhancer activity in single cells. Mol Cell. 66(2):285–299.e5. doi: 10.1016/j.molcel.2017.03.007
   PubMed Web of Science ®Google Scholar
• Yau EH, Kummetha IR, Lichinchi G, Rana TM. 2017. Genome-wide CRISPR screen for essential cell growth mediators in mutant KRAS colorectal cancers. Cancer Res. 77(22):6330–6339. doi: 10.1158/0008-5472.CAN-17-2043
   PubMed Web of Science ®Google Scholar
• Yin Y, Yan P, Lu J. 2015. Opposing roles for the lncRNA haunt and its genomic locus in regulating HOXA gene activation during embryonic stem cell differentiation. Cell Stem Cell. 16(5):504–516. doi: 10.1016/j.stem.2015.03.007
   PubMed Web of Science ®Google Scholar
• Zheng GX, Terry JM, Belgrader P. 2017. Massively parallel digital transcriptional profiling of single cells. Nat Commun. 8:1–12. doi: 10.1038/s41467-016-0009-6
   PubMed Web of Science ®Google Scholar
• Zhu S, Li W, Liu J. 2016. Genome-scale deletion screening of human long non-coding RNAs using a paired-guide RNA CRISPR-Cas9 library. Nat Biotechnol. 34(12):1279–1286. doi: 10.1038/nbt.3715
   PubMed Web of Science ®Google Scholar
• Ziegenhain C, Vieth B, Parekh S. 2017. Comparative analysis of single-cell RNA sequencing methods. Mol Cell. 65(4):631–643.e4. doi: 10.1016/j.molcel.2017.01.023
   PubMed Web of Science ®Google Scholar